Chronic fatigue syndrome

JAMA

Volumn 285, Issue 20, 2001, Pages 2557-2559

  Natelson, Benjamin H ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DISOPYRAMIDE; FLUDROCORTISONE;

CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; FUNCTIONAL DISEASE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DEFICIENCY; ORTHOSTATIC HYPOTENSION; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; SOMATIZATION; SYMPTOM; TILT TABLE TEST; UNITED STATES; VIRUS INFECTION;

EID: 0035938707     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.20.2557     Document Type: Review

References (47)

1. Buchwald D, Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med. 1994; 154:2049-2053.
2. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet. 1999;354: 936-939.
3. Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 1994; 37:1593-1601.
4. Evengard B, Nilsson CG, Lindh G, et al. Chronic fatigue syndrome differs from fibromyalgia: no evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain. 1998;78:153-155.
5. Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition Ann Intern Med. 1988;108:387-389.
6. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med. 1994;121:953-959.
7. Jason LA, Richman JA, Rademaker AW, et al. A community-based study of chronic fatigue syndrome. Arch Intern Med. 1999;159:2129-2137.
8. Komaroff AL, Fagioli LR, Doolittle TH, et al. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med. 1996;101:281-290.
9. Gold D, Bowden R, Sixbey J, et al. Chronic fatigue: a prospective clinical and virologic study. JAMA. 1990;264:48-53.
10. Zhang Q, Natelson BH, Ottenweller JE, et al. Chronic fatigue syndrome beginning suddenly occurs seasonally over the year. Chronobiol Int. 2000; 17:95-99.
11. White PD, Thomas JM, Amess J, et al. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry. 1998;173:475-481.
12. Hotopf M, Noah N, Wessely S. Chronic fatigue and minor psychiatric morbidity after viral meningitis: a controlled study. J Neurol Neurosurg Psychiatry. 1996;60:504-509.
13. Strober W. Immunological function in chronic fatigue syndrome. In: Straus S, ed Chronic Fatigue Syndrome. New York, NY: Marcel Dekker Inc; 1994: 207-237.
14. Zhang Q, Zhou X, Denny T, et al. Changes in immune parameters in Gulf War veterans but not in civilians with chronic fatigue syndrome. Clin Diagn Lab Immunol. 1999;6:6-13.
15. Von Mikecz A, Konstantinov K, Buchwald DS, Gerace L, Tan EM. High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. Arthritis Rheum. 1997;40:295-305.
16. DeMeirleir K, Bisbal C, Campine I, et al. A 37 kDa 25A binding protein as a potential biochemical marker for chronic fatigue syndrome Am J Med. 2000;108: 99-105.
17. Strayer DR, Carter WA, Brodsky I, et al. A controlled clinical trial with a specifically configured RNA drug, poly(I) poly(C12U), in chronic fatigue syndrome. Clin Infect Dis. 1994;18(suppl 1):S88-S95.
18. Johnson SK, DeLuca J, Natelson BH. Depression in fatiguing illness: comparing patients with chronic fatigue syndrome, multiple sclerosis and depression. J Affect Disord. 1996;39:21-30.
19. Johnson SK, DeLuca J, Natelson BH. Personality dimensions in the chronic fatigue syndrome: a comparison with multiple sclerosis and depression. J Psychiatr Res. 1996;31:9-20.
20. Natelson BH, Denny T, Zhou XD, et al. Is depression associated with immune activation? J Affect Disord. 1999;53:179-184.
21. Scott LV, Dinan TG. The neuroendocrinology of chronic fatigue syndrome: focus on the hypothalamic-pituitary adrenal axis. Funct Neurol. 1999;14:3-11.
22. Johnson SK, DeLuca J, Natelson BH. Assessing somatization disorder in the chronic fatigue syndrome. Psychosom Med. 1996;58:50-57.
23. Hickie I, Lloyd A, Hadzi-Pavlovic D, Parker G, Bird K, Wakefield D. Can chronic fatigue syndrome be defined by distinct clinical features? Psychol Med. 1995; 25:925-935.
24. Katon W, Russo J. Chronic fatigue syndrome criteria: a critique of the requirement for multiple physical complaints. Arch Intern Med. 1992;152:1604-1609.
25. Thompson D, Hylan TR, McMullen W, Romeis ME, Buesching D, Oster G. Predictors of a medical-offset effect among patients receiving antidepressant therapy. Am J Psychiatry. 1998;155:824-827.
26. Wessely S, Hotopf M, Sharpe M. Chronic Fatigue and Its Syndromes. London, England: Oxford University Press; 1998.
27. Sharpe M, Hawton K, Simkin S, et al. Cognitive behaviour therapy for the chronic fatigue syndrome: a randomised controlled trial. BMJ. 1996;312:22-26.
28. Deale A, Chalder T, Marks I, Wessely S. Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial. Am J Psychiatry. 1997; 154:408-414.
29. Parker JC, Iverson GL, Smarr KL, Stucky-Ropp RC. Cognitive-behavioral approaches to pain management in rheumatoid arthritis. Arthritis Care Res. 1993; 6:207-212.
30. Lloyd AR, Hickie I, Brockman A, et al. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo controlled trial. Am J Med. 1993;94:197-203.
31. Friedberg F, Krupp LB. A comparison of cognitive behavioral treatment for chronic fatigue syndrome and primary depression. Clin Infect Dis. 1994; 18(suppl 1):S105-S110.
32. Friedberg F. A subgroup analysis of cognitive behavioral treatment studies. J Chronic Fatigue Syndr. 2000;5:149-159.
33. Bou-Holaigah I, Rowe PC, Kan J, Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA. 1995;274: 961-967.
34. Rowe PC, Calkins H, DeBusk K, et al. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA. 2001;285:52-59.
35. LaManca JJ, Peckerman A, Walker J, et al. Cardiovascular response during head-up tilt in chronic fatigue syndrome. Clin Physiol. 1999;19:111-120.
36. Poole J, Herrell R, Ashton S, Goldberg J, Buchwald D. Results of isoproterenol tilt table testing in monozygotic twins discordant for chronic fatigue syndrome. Arch Intern Med. 2000;160:3461-3468.
37. Lerner AM, Goldstein J, Chang C, et al. Cardiac involvement in patients with chronic fatigue syndrome as documented with Holter and biopsy data in Birmingham, Michigan, 1991-1993. Infect Dis Clin Pract. 1997;6:327-333.
38. Streeten DHP, Bell DS. Circulating blood volume in chronic fatigue syndrome. J Chronic Fatigue Syndr. 1998;4:3-11.
39. Schondorf R, Benoit J, Wein T, Phaneuf D. Orthostatic intolerance in the chronic fatigue syndrome. J Autonom Nerv Sys. 1999;75:192-201.
40. Streeten DHP, Anderson GH. The role of delayed orthostatic hypotension in the pathogenesis of chronic fatigue. Clin Auton Res. 1998;8: 119-124.
41. Stewart JM, Gewitz MH, Weldon A, Arlievsky N, Li K, Munoz J. Orthostatic intolerance in adolescent chronic fatigue syndrome. Pediatrics. 1999;103:116-121.
42. DeLuca J, Johnson SK, Beldowicz D, Natelson BH. Neuropsychological impairments in chronic fatigue syndrome, multiple sclerosis, and depression. J Neurol Neurosurg Psychiatry. 1995;58:38-43.
43. DeLuca J, Johnson SK, Ellis SP, Natelson BH. Cognitive functioning is impaired in chronic fatigue syndrome patients devoid of psychiatric disease. J Neurol Neurosurg Psychiatry. 1997;62:151-155.
44. Christodoulou C, DeLuca J, Lange C, et al. Relation between neuropsychological impairment and functional disability in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry. 1998;64: 431-434.
45. Lange G, DeLuca J, Maldjian JA, Lee HJ, Tiersky LA, Natelson BH. Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome. J Neurol Sci. 1999;171:3-7.
46. Cook DB, Lange G, DeLuca J, Natelson BH. Relationship of brain MRI abnormalities and physical functional status in CFS. Int J Neurosci. 2001;107:1-6.
47. Natelson BH. Facing and Fighting Fatigue: A Practical Approach. New Haven, Conn: Yale University Press; 1998.